Published in Isr J Health Policy Res on November 26, 2012
Oncologists' and family physicians' views on value for money of cancer and congestive heart failure care. Isr J Health Policy Res (2013) 0.97
Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation. Pharmacoeconomics (2016) 0.88
Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA). BMC Health Serv Res (2015) 0.84
Does cancer deserve special treatment when health technologies are prioritized? Isr J Health Policy Res (2013) 0.79
Priority setting: the importance of incorporating opportunity costs. Isr J Health Policy Res (2012) 0.75
Towards improving the ethics of ecological research. Sci Eng Ethics (2014) 0.75
Do the equity-efficiency preferences of the Israeli Basket Committee match those of Israeli health policy makers? Isr J Health Policy Res (2017) 0.75
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med (2001) 7.94
Principles for allocation of scarce medical interventions. Lancet (2009) 4.55
The second phase of priority setting. Goodbye to the simple solutions: the second phase of priority setting in health care. BMJ (1998) 4.03
Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be? J Health Econ (1992) 3.33
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis Rheum (2010) 1.94
Priority setting in health care: Lessons from the experiences of eight countries. Int J Equity Health (2008) 1.89
Year 2006 update of the Israel National List of Health Services. Isr Med Assoc J (2006) 1.49
Incremental cost-effectiveness ratios (ICERs): the silence of the lambda. Soc Sci Med (2005) 1.47
The second phase of priority setting. Israel's basic basket of health services: the importance of being explicitly implicit. BMJ (1998) 1.36
Health technology prioritization: which criteria for prioritizing new technologies and what are their relative weights? Health Policy (2010) 1.28
Prioritizing patients for elective surgery: a systematic review. ANZ J Surg (2003) 1.25
Health technology funding decision-making processes around the world: the same, yet different. Pharmacoeconomics (2011) 1.23
A system for rating the stability and strength of medical evidence. BMC Med Res Methodol (2006) 1.19
Justice and solidarity in priority setting in health care. Health Care Anal (2003) 1.11
Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada. BMC Health Serv Res (2011) 1.06
An ethical analysis of international health priority-setting. Health Care Anal (2007) 1.02
The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold. J Health Serv Res Policy (2006) 1.00
An equity framework for health technology assessments. Med Decis Making (2011) 0.96
[Updating the basket of health services]. Harefuah (2003) 0.95
The process of updating the National List of Health Services in Israel: is it legitimate? Is it fair? Int J Technol Assess Health Care (2009) 0.93
Relative urgency for referral from primary care to rheumatologists: the Priority Referral Score. Arthritis Care Res (Hoboken) (2011) 0.91
Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials. J Rheumatol (2011) 0.88
Value for money - recasting the problem in terms of dynamic access prioritisation. Disabil Rehabil (2010) 0.79
Balancing relevant criteria in allocating scarce life-saving interventions. Am J Bioeth (2010) 0.78
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects. Rheumatology (Oxford) (2017) 0.75
Qualitative Development of a Discrete Choice Experiment for Physical Activity Interventions to Improve Knee Osteoarthritis. Arch Phys Med Rehabil (2016) 0.75
The quality-of-life burden of knee osteoarthritis in New Zealand adults: A model-based evaluation. PLoS One (2017) 0.75